Journal ArticleDOI
American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography.
Sherif F. Nagueh,S. Michelle Bierig,Matthew J. Budoff,Milind Y. Desai,Vasken Dilsizian,Benjamin W. Eidem,Steven A. Goldstein,Judy Hung,Martin S. Maron,Steve R. Ommen,Anna Woo +10 more
TLDR
This research presents a meta-analyses of the determinants of infectious disease outbreaks in eight operation theatres across the United States and Canada over a period of 12 months in the period of May 21 to 29, 2012.Abstract:
Sherif F. Nagueh, MD, FASE, Chair,* S. Michelle Bierig, RDCS, FASE,* Matthew J. Budoff, MD, Milind Desai, MD,* Vasken Dilsizian, MD, Benjamin Eidem, MD, FASE,* Steven A. Goldstein, MD,* Judy Hung, MD, FASE,* Martin S. Maron, MD, Steve R. Ommen, MD,* and Anna Woo, MD,*Houston, Texas; St. Louis, Missouri; Los Angeles, California; Cleveland, Ohio; Baltimore, Maryland; Rochester, Minnesota; Washington, District of Columbia; Boston, Massachusetts; Toronto, Ontario, Canadaread more
Citations
More filters
Journal ArticleDOI
The Remarkable 50 Years of Imaging in HCM and How it Has Changed Diagnosis and Management: From M-Mode Echocardiography to CMR
Barry J. Maron,Martin S. Maron +1 more
TL;DR: The almost 50-year odyssey of cardiac imaging in hypertrophic cardiomyopathy (HCM), revisited and described here, has been remarkable, particularly when viewed in the timeline of advances that occurred during a single generation of investigators.
Journal ArticleDOI
Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography.
TL;DR: Although guidelines recommend MRI or TTE imaging to assess cardiac anatomy in HC, this study shows discrepancy between the techniques for maximal reported LV wall thickness assessment, and efforts to resolve these discrepancies are critical.
Journal ArticleDOI
A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life
Chiara Calore,Marzia De Bortoli,Chiara Romualdi,Alessandra Lorenzon,Annalisa Angelini,Cristina Basso,Gaetano Thiene,Sabino Iliceto,Alessandra Rampazzo,Paola Melacini +9 more
TL;DR: Low survival due to sudden cardiac death (SCD) or aborted SCD occurred more frequently after the fourth decade of life in probands carrying p.F305Pfs*27 mutation than those without MYBPC3 mutations.
Journal ArticleDOI
Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
Dai Yin Lu,Dai Yin Lu,Dai Yin Lu,Iraklis Pozios,Bereketeab Haileselassie,Ioannis Ventoulis,Hongyun Liu,Lars Sorensen,Marco Canepa,Susan Phillip,M. Roselle Abraham,Theodore P. Abraham,Theodore P. Abraham +12 more
TL;DR: The data suggest detailed sudden cardiac death risk stratification in nonobstructive HCM and monitoring with less aggressive management in labile HCM.
Journal ArticleDOI
Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: the importance of clinical context.
Giovanni Quarta,Giovanni Donato Aquaro,Patrizia Pedrotti,Gianluca Pontone,Santo Dellegrottaglie,Attilio Iacovoni,Paolo Brambilla,Silvia Pradella,Giancarlo Todiere,Fausto Rigo,Chiara Bucciarelli-Ducci,Giuseppe Limongelli,Alberto Roghi,Iacopo Olivotto +13 more
TL;DR: The role of CMR in managing HCM is summarized and the importance of the clinical context in which the report is provided is reviewed, in both adult and paediatric population, highlighting implications for clinical research.
References
More filters
Journal ArticleDOI
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.
Roberto M. Lang,Michelle Bierig,Richard B. Devereux,Frank A. Flachskampf,Elyse Foster,Patricia A. Pellikka,Michael H. Picard,Mary J. Roman,James B. Seward,Jack S. Shanewise,Scott D. Solomon,Kirk T. Spencer,Martin St. John Sutton,William J. Stewart +13 more
TL;DR: Members of the Chamber Quantification Writing Group are: Roberto M. Lang, MD, Fase, Michelle Bierig, MPH, RDCS, FASE, Richard B. Devereux,MD, Frank A. Flachskampf, MD and Elyse Foster, MD.
Journal ArticleDOI
Recommendations for the evaluation of left ventricular diastolic function by echocardiography
Sherif F. Nagueh,Christopher P. Appleton,Thierry C. Gillebert,Paolo Marino,Jae K. Oh,Otto A. Smiseth,Alan D. Waggoner,Frank A. Flachskampf,Patricia A. Pellikka,Arturo Evangelista +9 more
TL;DR: Recommendations for the evaluation of left ventricular diastolic function by echocardiography are made and further research is needed to determine the best method for this evaluation.
Journal ArticleDOI
Recommendations for the evaluation of left ventricular diastolic function by echocardiography
Sherif F. Nagueh,Christopher P. Appleton,Thierry C. Gillebert,Paolo Marino,Jae K. Oh,Otto A. Smiseth,Alan D. Waggoner,Frank A. Flachskampf,Patricia A. Pellikka,Arturo Evangelisa +9 more
TL;DR: The assessment of left ventricular (LV) diastolic function and filling pressures is of paramount clinical importance to distinguish this syndrome from other diseases such as pulmonary disease resulting in dyspnea, to assess prognosis, and to identify underlying cardiac disease and its best treatment.
Journal ArticleDOI
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
Barry J. Maron,William J. McKenna,Gordon K. Danielson,Lukas Kappenberger,Horst J. Kuhn,Christine E. Seidman,Pravin M. Shah,William H. Spencer,Paolo Spirito,Folkert J. Ten Cate,E. Douglas Wigle,Robert A. Vogel,Jonathan Abrams,Eric R. Bates,Bruce R. Brodie,Peter G. Danias,Gabriel Gregoratos,Mark A. Hlatky,Judith S. Hochman,Sanjiv Kaul,Robert C. Lichtenberg,Jonathan R. Lindner,Robert A. O'Rourke,Gerald M. Pohost,Richard S. Schofield,Cynthia M. Tracy,William L. Winters,Werner Klein,Silvia G. Priori,Angeles Alonso-Garcia,Carina Blomström-Lundqvist,Guy De Backer,Jaap W. Deckers,Markus Flather,Jaromír Hradec,Ali Oto,Alexander Parkhomenko,Sigmund Silber,Adam Torbicki +38 more
TL;DR: In this paper, the authors present a general approach for the natural history and clinical course of clinical diagnostics in the context of vascular flow outflow and genetic and molecular diagnostics.
Journal ArticleDOI
ACCF/ACR/SCCT/SCMR/ ASNC/NASCI/SCAI/SIR 2006 Appropriateness Criteria for Cardiac Computed Tomography and Cardiac Magnetic Resonance Imaging*
Robert C. Hendel,Manesh R. Patel,Christopher M. Kramer,Michael Poon,James C. Carr,Nancy A. Gerstad,Linda D. Gillam,John McB. Hodgson,Raymond J. Kim,John R. Lesser,Edward T. Martin,Joseph V. Messer,Rita F. Redberg,Geoffrey D. Rubin,John S. Rumsfeld,Allen J. Taylor,Wm. Guy Weigold,Pamela K. Woodard,Ralph G. Brindis,Pamela S. Douglas,Eric D. Peterson,Michael J. Wolk,Joseph M. Allen +22 more
TL;DR: Use of tests for structure and function and for diagnosis in symptomatic, intermediate coronary artery disease (CAD) risk patients was deemed appropriate, while repeat testing and general screening uses were viewed less favorably.
Related Papers (5)
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
Perry M. Elliott,Aris Anastasakis,Michael A. Borger,Martin Borggrefe,Franco Cecchi,Philippe Charron,Albert Hagège,Antoine Lafont,Giuseppe Limongelli,Heiko Mahrholdt,William J. McKenna,Jens Mogensen,Petros Nihoyannopoulos,Stefano Nistri,Petronella G. Pieper,Burkert Pieske,Claudio Rapezzi,Frans H. Rutten,Christoph Tillmanns,Hugh Watkins +19 more